✦ LIBER ✦

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

✍ Scribed by Aurelio Maggio; Angela Vitrano; Marcello Capra; Liana Cuccia; Francesco Gagliardotto; Aldo Filosa; Carmelo Magnano; Michele Rizzo; Vincenzo Caruso; Calogera Gerardi; Crocetta Argento; Saveria Campisi; Francesco Cantella; Francesca Commendatore; Domenico Giuseppe D'Ascola; Carmelo Fidone; Angela Ciancio; Maria Concetta Galati; Gaetano Giuffrida; Rocca Cingari; Giovanni Giugno; Turi Lombardo; Luciano Prossomariti; Roberto Malizia; Anna Meo; Gaetano Roccamo; Maria Antonietta Romeo; Pietro Violi; Paolo Cianciulli; Paolo Rigano

Book ID: 116304648
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 370 KB
Volume: 42
Category: Article
ISSN: 1079-9796
DOI: 10.1016/j.bcmd.2009.01.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB